AI will help find cure for cancer ‘within our lifetimes’, says Arm Holdings chief
Rene Haas also claims artificial intelligence could pave way for widespread use of humanoid robots within five years Business live – latest updates The boss of one of the UK’s biggest chip companies has claimed AI will be able to find a cure for cancer “in our lifetime”. Rene Haas, chief executive of the chip designer Arm Holdings, said that, while modelling how a DNA marker is affected by cancer…
Arm Holdings CEO Rene Haas believes artificial intelligence will be able to discover a cure for cancer within our lifetime. While modeling the impact of DNA markers on cancer is currently too complex for humans or existing technology, Haas is confident that AI will eventually solve the issue as computers become more sophisticated and powerful.
He stated that modelling the impact of a DNA marker on cancer is too complex a problem for both humans and current AI systems. However, as more models are fed into these computers and the technology advances, they will eventually uncover the cure. In addition to finding a cancer cure, Haas predicts that AI will also lead to the widespread use of humanoid robots within the next five years.
These robots will be able to see, learn, and reprogrammed for new tasks, making them adaptable for various roles in the service industry. However, Haas also mentioned that chip shortages are currently hindering the growth of this area. Arm Holdings, with its headquarters in Cambridge and about 7,000 employees worldwide, is the biggest technology company in Britain.
The company is valued at $269 billion and has significant clients including Apple, Samsung, Qualcomm, and Nvidia.
Written by urgent.news from Guardian Business's reporting — not their text. Machine-written — may contain errors; check the original before relying on it.
This story
This is one outlet's version. Read the fullest account.